Completed
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
NCT03197623
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +8 more
- Locations
-
- West Coast Clinical Trials (WCCT) Cypress, California, United States
- Diablo Clinical Research Walnut Creek, California, United States
- Altoona Center for Clinical Research Duncansville, Pennsylvania, United States
- Metroplex Clinical Research Center Dallas, Texas, United States